- Human pathology

Home > A. Molecular pathology > Targeted therapy > CCR2 inhibitors

CCR2 inhibitors

Friday 10 June 2016


- CCX140-B
- CCX872

Chemokine receptor CCR2 mediates monocyte mobilization from the bone marrow (BM) and subsequent migration into target tissues.

CCR2 is highly expressed by inflammatory monocytes, dendritic cells, plasmacytoid dendritic cells and NK cells in all tissues.

Results demonstrate the central role CCR2 plays in mediating leukocyte mobilization from the BM, and suggest a role for CCR2 inhibition in managing monocytes/macrophages-mediated chronic inflammatory conditions.